論文 - 岡本 哲平
-
Serum Serotonin Levels as a Potential Risk Factor for Overactive Bladder in a Community-Dwelling Population: A Four-Year Longitudinal Study.
Fukushima T, Okamoto T, Hamaya T, Kodama H, Fujita N, Yamamoto H, Imai A, Nakaji S, Hatakeyama S.
Lower Urinary Tract Symptoms 2026年07月
-
Overactive Bladder Symptoms as a Predictor of Longitudinal Decline in Grip Strength in Community-Dwelling Men: A 4-Year Longitudinal Study.
Sato H, Okamoto T, Hamaya T, Kodama H, Narita T, Mikami J, Fujita N, Yamamoto H, Imai A, Murashita K, Nakaji S, Hatakeyama S.
Lower Urinary Tract Symptoms 2026年03月
-
The long-term impact of mild COVID-19 on cardiovascular disease and mortality in patients on hemodialysis: a post-Omicron era retrospective observational study.
Okamoto A, Okamoto T, Ichiyama T, Fukushima T, Omizo S, Asanuma H, Sato H, Sakurai H, Yoneyama A, Yoneyama F, Ishii N, Oishi T, Tanaka R, Miura H, Hamaya T, Kodama H, Fujita N, Murasawa H, Yamamoto H, Imai A, Saitoh H, Hatakeyama S, Ohyama C, Suzuki T.
Renal Failure 2025年06月
-
Pre-transplant tacrolimus fluctuations predict BK virus infection risk in kidney transplants
Hisashi Sakurai, Teppei Okamoto, Anna Yoneyama, Fumiya Yoneyama, Tomoko Hamaya, Hirotake Kodama, Naoki Fujita, Hayato Yamamoto, Kazuyuki Mori, Takeshi Fujita, Atushi Imai, Reiichi Murakami, Hirofumi Tomita,Shingo Hatakeyama, Chikara Ohyama
Clinical and Experimental Nephrology 2025年03月
-
パイロット研究；抗癌剤治療を要する進行尿路上皮癌患者を対象とした人参養栄湯によるサルコペニア予防効果の検討（単施設、単群、非盲検化試験）
岡本 哲平
新薬と臨床 73 ( 8 ) 759 - 769 2024年08月
-
Impact of Gleason pattern 5 on prognosis for newly diagnosed metastatic hormone-sensitive prostate cancer with Gleason score ≥8
Kento Morozumi,Koji Mitsuzuka,Shintaro Narita,Masahiro Takahashi,Sadafumi Kawamura,Tatsuo Tochigi,Yoichi Arai,Senji Hoshi,Jiro Shimoda,Shigeto Ishidoya,Teppei Okamoto,Shingo Hatakeyama,Toshihiko Sakurai,Norihiko Tsuchiya,Chikara Ohyama,Tomonori Habuchi,Akihiro Ito
2022年01月
-
The influence of gut microbiome on progression of overactive bladder symptoms: a community-based 3-year longitudinal study in Aomori, Japan
Okuyama Y, Okamoto T, Sasaki D, Ozaki K, Songee J, Hatakeyama S, Mikami T, Ohyama C.
International Urology and Nephrology 2021年10月
-
Butyrylcholinesterase level as an independent prognostic factor for overall survival in patients on maintenance hemodialysis: a single-center retrospective study
Fukushi K, Okamoto T, Ozaki Y, Ozaki K, Sasaki D, Miura Y, Okuyama Y, Tanaka Y, Imanishi K, Hatakeyama S, Saitoh F, Ohyama C.
Clinical and Experimental Nephrology 2021年09月
-
Association of Prophylactic Intravenous Corticosteroid Premedication With Toxicity and Survival in Patients Receiving Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Carcinoma.
Shinohara M, Yamamoto H, Kawashima Y, Sekine Y, Narita S, Kobayashi S, Abe N, Kodama H, Fujita N, Okamoto T, Numakura K, Sato S, Habuchi T, Ohyama C, Hatakeyama S.
International Journal of Urology 2026年03月
-
Deferred Cytoreductive Nephrectomy in Unresectable/Metastatic Renal Cell Carcinoma: A Real-World Multicenter Retrospective Study.
Tanaka R, Shinohara M, Kawashima Y, Sekine Y, Narita S, Kobayashi S, Abe N, Kodama H, Fujita N, Okamoto T, Yamamoto H, Numakura K, Sato S, Habuchi T, Ohyama C, Hatakeyama S.
International Journal of Urology 2026年01月
-
Immediate Postoperative cfDNA Elevation Predicts Pain After Robot-Assisted Radical Prostatectomy.
Ishii N, Yoneyama T, Minakawa S, Konishi S, Kodama H, Narita T, Mikami J, Fujita N, Okamoto T, Yamamoto H, Imai A, Ohyama C, Hatakeyama S.
International Journal of Urology 2026年01月
-
Integrated Assessment of Percentage α2,3-Linked Sialylated Prostate-specific Antigen and the Prostate Health Index with Magnetic Resonance Imaging for Detection of Clinically Significant Prostate Cancer.
Oishi T, Yoneyama T, Miura Y, Hamaya T, Kodama H, Narita T, Mikami J, Fujita N, Okamoto T, Yamamoto H, Imai A, Ohyama C, Hatakeyama S.
European Urology Open Science 2025年12月
-
Effects of Avelumab Maintenance on Advanced Urothelial Carcinoma: A Real-World Multicenter Study
Ishii N, Sekine Y, Shinohara M, Kawashima Y, Mori K, Kobayashi M, Numakura K, Mikami J, Fujita N, Okamoto T, Yoneyama T, Tabata R, Sato S, Habuchi T, Ohyama C, Hatakeyama S.
Cancer Medicine 2025年09月
-
PD-L1 and Ki-67 Expression Before and After Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer.
Sasaki D, Yoneyama T, Yoneyama F, Ozaki K, Ozaki Y, Miura Y, Fujita N, Okamoto T, Yamamoto H, Goto S, Yoshizawa T, Kurose A, Kijima H, Ohyama C, Hatakeyama S.
International Journal of Urology 2025年09月
-
The Effects of the Blood-Based S2,3PSA% Test on Prostate Cancer Screening: A Novel Approach to Reduce the Need for MRI and Unnecessary Biopsies.
Miura H, Hamaya T, Yoneyama T, Shimoyama T, Tsushima F, Togashi K, Miura Y, Yoneyama A, Sato H, Omizo S, Mori K, Kodama H, Fujita N, Okamoto T, Yamamoto H, Kakeda S, Ohyama C, Hatakeyama S.
Prostate 2025年08月
-
Effects of Robot-Assisted Radical Cystectomy on Peritoneal Carcinomatosis and Prognosis in Patients With Muscle-Invasive Bladder Cancer: A Multicenter Retrospective Study.
Yoneyama F, Shinohara M, Kawashima Y, Yoneyama A, Ishii N, Oishi T, Tanaka R, Miura H, Kodama H, Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Sato S, Ohyama C, Hatakeyama S.
International Journal of Urology 2025年08月
-
Efficacy of modified enfortumab vedotin ineligible criteria (mEVITA) in advanced urothelial carcinoma.
Fukushima T, Numakura K, Shinohara M, Kawashima Y, Sekine Y, Mori K, Kobayashi M, Asanuma H, Ichiyama T, Sakurai H, Ozaki K, Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Sato S, Habuchi T, Ohyama C, Hatakeyama S.
Scientific Reports 2025年07月
-
Analytical and Real-World Clinical Characterization of S2,3PSA% Test in MRI Fusion Targeted Prostate Biopsy Population. Prostate.
Miura Y, Yoneyama T, Yamamoto H, Suzuki H, Otsubo T, Fujita E, Tsushima F, Goto S, Okamoto T, Fujita N, Ishiyama M, Yoshizawa T, Kakeda S, Hatakeyama S, Ohyama C.
Prostate 2025年03月
-
Multicenter, international, retrospective study of prognostic factors for Ra223.
Oishi T, Luo HL, Hatayama Y, Kawaguchi H, Sasaki D, Tanaka R, Ishii N, Mikami J, Okamoto T, Yamamoto H, Aoki M, Su YL, Chen YH, Chang YH, Chen YT, Wang HJ, Ohyama C, Hatakeyama S.
Scientific Reports 2025年03月
-
Impact of Skin Adverse Events on Prognosis in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin: A Real-World Multicenter Study
2025年03月